Treatment of Vitamin B12 Deficiency after Gastric Surgery for Severe Obesity |
| |
Authors: | Barbara M Rhode PDt MSc CNSD Hala Tamim MPH Brian M Gilfix MDCM PhD FRCP John S Sampalis PhD Carl Nohr MD PhD FRCS FACS Lloyd D MacLean MD FRCS FACS |
| |
Affiliation: | (1) Departments of Surgery and Medicine, Division of Clinical Biochemistry, Royal Victoria Hospital, McGill University, Montreal, Canada;(2) Departments of Surgery and Medicine, Division of Clinical Biochemistry, Royal Victoria Hospital, McGill University, Montreal, Canada;(3) Departments of Surgery and Medicine, Division of Clinical Biochemistry, Royal Victoria Hospital, McGill University, Montreal, Canada;(4) Departments of Surgery and Medicine, Division of Clinical Biochemistry, Royal Victoria Hospital, McGill University, Montreal, Canada;(5) Departments of Surgery and Medicine, Division of Clinical Biochemistry, Royal Victoria Hospital, McGill University, Montreal, Canada;(6) Departments of Surgery and Medicine, Division of Clinical Biochemistry, Royal Victoria Hospital, McGill University, Montreal, Canada |
| |
Abstract: | Background: Vitamin B12 deficiency after gastric surgery for obesity is due to a failure of separation of vitamin B12 from protein foodstuffs and to a failure of absorption of crystalline vitamin B12 in the presence of intrinsic factor. The purpose of this study was to determine which of four oral doses of crystalline vitamin B12 was most effective in treating vitamin B12 deficiency in 102 patients. Methods and Results: At time of entry into the study, the patients had a serum vitamin B12 < 100 pmol L −1, were 29.9 ± 21.7 months post-op, were 37 ± 8 years old and had a body mass index of 30 ± 6 kg m−2. Eight (8%) had had a vertical banded gastroplasty and 94 (92%) a gastric bypass. For the first 3 months all patients received 350 μg per day of crystalline vitamin B12 and all increased their serum vitamin B12 levels to over 100 pmol L−1. The patients were then assigned to receive for a further 3 month period one of four oral doses of crystalline vitamin B12-100 μg, 250 μg, 350 μg and 600 μg. Serum vitamin B12 levels were greater than 150 pmol L−1 after 6 months in 83.3% of patients who received 100 μg; 92.3% of patients who received 250 μg; 94.7% after 350 μg and 95.2% after 600 μg (p%0.525). Conclusion: At least 350 μg per day is the appropriate oral dose of crystalline vitamin B12 after gastric surgery for obesity to correct low serum vitamin B12 levels in 95% of patients. |
| |
Keywords: | vitamin B12 supplementation oral post-operative serum gastric bypass gastroplasty severe obesity |
本文献已被 PubMed SpringerLink 等数据库收录! |
|